Company performance
Add to research
Current Price
as of Jun 18, 2025$2.29
P/E Ratio
N/A
Market Cap
$47.84M
Description
Add to research
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Metrics
Add to research
Overview
- HQRedwood City, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerADVM
- Price$2.29-1.29%
Trading Information
- Market cap$47.84M
- Float66.22%
- Average Daily Volume (1m)186,444
- Average Daily Volume (3m)340,377
- EPS-$6.39
Company
- Revenue$1.00M
- Rev growth (1yr)N/A
- Net income-$47.02M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$47.54M
- EV$101.59M
- EV/Revenue101.59
- P/EN/A
- P/S47.95
- P/B1.81
- Debt/Equity352.65
Documents
Add to research
SEC Filings
Factset Street Account
Factset